# Phio Pharmaceuticals Corp.: Form 8-K, filed Oct 25, 2019

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 8-K
- Filed: 2019-10-25
- Accepted by EDGAR: Oct 25, 2019, 17:25 ET
- Period: 2019-10-24
- Accession: 0001683168-19-003370
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000168316819003370/phio_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000168316819003370/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000168316819003370/phio_8k.htm

Filed Oct 25, 2019.
Source: SEC EDGAR, the filing index for accession 0001683168-19-003370. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
